Vinge has assisted Vostok New Ventures Ltd (“Vostok”) in connection with an investment by a number of investors in Voi Technology AB, a company that provides an electric scooter sharing service.
The board of directors of Hansa Medical has resolved on a directed new issue of shares, whereby Hansa Medical will raise proceeds of approximately SEK 453 / USD 50 million, before issue costs.
Vinge has advised Irisity AB (publ), Nasdaq First North, in connection with a directed new issue of shares to Nordic institutional and private investors.
William Hill has launched a recommended cash offer to the shareholders in Mr Green & Co, MRG (Nasdaq Stockholm). The total offer value for all shares in MRG amounts to approximately SEK 2.819 billion.
Galecto Biotech AB, the developer of galectin modulators for the treatment of severe diseases, including fibrosis and cancer, has closed a €79 million financing co-led by Ysios Capital and OrbiMed.
Vinge has advised Bilia AB (publ) in connection with the issue of new senior and non subordinated bonds with a framework amount of SEK 1 500 000 000 as well as the repurchase of SEK 500 000 000 of a previously issued senior and non subordinated bond with a maturity date in 2021.
Klövern AB (publ) has, through its indirectly wholly-owned subsidiary Dagon Sverige AB, made a public cash offer to the shareholders of A Group Of Retail Assets Sweden AB (publ) (Nasdaq First North).
Vinge has assisted Vostok New Ventures Ltd (“Vostok”) in connection with its investment in Voi Technology AB, a company that provides an electric scooter sharing service.
Vinge has advised Smart Eye AB (publ) in connection with a directed issue of new shares to institutional investors as a result of which Swedbank Robur Ny Teknik will become a significant owner with 7.6% of the votes and capital.
